Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29580297 | 1.00 | CA12 (0.33) | CA12CA1CA2CA7CA13 | |
| SCHEMBL15624384 | 0.77 | ALDH1A1 (0.31) | ALDH1A1LMNACES2CES1 | |
| SCHEMBL4850782 | 0.72 | MEN1 (0.31) | — | |
| SCHEMBL11942296 | 0.72 | POLB (0.35) | CA12CA1CA2CA7CA13 | |
| SCHEMBL18700724 | 0.72 | HDAC1 (0.31) | — | |
| SCHEMBL24103030 | 0.72 | — | — | |
| SCHEMBL30930521 | 0.72 | ALDH1A1 (0.38) | CA12CA1CA2CA7CA13 | |
| SCHEMBL1099814 | 0.72 | — | — | |
| SCHEMBL1099817 | 0.72 | KMT2A (0.30) | — | |
| SCHEMBL16908181 | 0.72 | ALDH1A1 (0.38) | CA12CA1CA2CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3149020-A2 | CHEMICALLY MODIFYING PEPTIDES | The University of Durham (GB) | 2017-04-05 | — | — | EP | claimed |
| EP-3149021-A1 | CYCLISING PEPTIDES | The University of Durham (GB) | 2017-04-05 | — | — | EP | claimed |
| WO-2015181545-A1 | CYCLISING PEPTIDES | THE UNIVERSITY OF DURHAM (GB) | 2015-12-03 | — | — | WO | claimed |
| WO-2015181544-A2 | CHEMICALLY MODIFYING PEPTIDES | THE UNIVERSITY OF DURHAM (GB) | 2015-12-03 | — | — | WO | claimed |
| EP-4363409-B1 | METHOD FOR THE PRODUCTION OF ALKYLENE OXIDES | COVESTRO DEUTSCHLAND AG (DE) | 2025-06-11 | — | — | EP | disclosed |
| EP-4363409-A1 | METHOD FOR PRODUCING ALKYLENE OXIDES | Covestro Deutschland AG (DE) | 2024-05-08 | — | — | EP | disclosed |
| CN-117448850-A | Universal method for preparing polyfluoro biaryl compound without transition metal | 中国科学院理化技术研究所 | 2024-01-26 | — | — | CN | disclosed |
| WO-2023274993-A1 | METHOD FOR PRODUCING ALKYLENE OXIDES | COVESTRO DEUTSCHLAND AG (DE) | 2023-01-05 | — | — | WO | disclosed |
| EP-4112609-A1 | METHOD FOR THE PRODUCTION OF ALKYLENE OXIDES | Covestro Deutschland AG (DE) | 2023-01-04 | — | — | EP | disclosed |
| CN-110491999-B | Modification method of electron transport layer for organic solar cell | 太原理工大学 | 2022-04-12 | — | — | CN | disclosed |
| US-10906932-B2 | Cyclising peptides | THE UNIVERSITY OF DURHAM (GB) | 2021-02-02 | — | — | US | disclosed |
| US-10906932-B2 | Cyclising peptides | THE UNIVERSITY OF DURHAM (GB) | 2021-02-02 | — | — | US | disclosed |
| WO-2015181545-A1 | CYCLISING PEPTIDES | THE UNIVERSITY OF DURHAM (GB) | 2015-12-03 | — | — | WO | disclosed |
| WO-2015181544-A2 | CHEMICALLY MODIFYING PEPTIDES | THE UNIVERSITY OF DURHAM (GB) | 2015-12-03 | — | — | WO | disclosed |
| WO-2010026075-A1 | PYRIDINE DERIVATIVES AS INHIBITORS OF HIV-I REVERSE TRANSCRIPTASE | F. HOFFMANN-LA ROCHE AG (CH) | 2010-03-11 | — | — | WO | disclosed |
| WO-2010026075-A1 | PYRIDINE DERIVATIVES AS INHIBITORS OF HIV-I REVERSE TRANSCRIPTASE | F. HOFFMANN-LA ROCHE AG (CH) | 2010-03-11 | — | — | WO | disclosed |
| US-20100056535-A1 | Inhibitors of HIV-1 reverse transcriptase | ROCHE PALO ALTO LLC | 2010-03-04 | — | — | US | disclosed |
| US-20100056535-A1 | Inhibitors of HIV-1 reverse transcriptase | ROCHE PALO ALTO LLC | 2010-03-04 | — | — | US | disclosed |
| US-20100056535-A1 | Inhibitors of HIV-1 reverse transcriptase | ROCHE PALO ALTO LLC | 2010-03-04 | — | — | US | disclosed |
| WO-1997049697-A1 | PYRIDYLAMINOPYRIMIDINES AS FUNGICIDES | ZENECA LIMITED (GB) | 1997-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056535-A1 | Inhibitors of HIV-1 reverse transcriptase | QTRT1, NQO2, QTRT2 | CA12 4842/4885CA1 4639/4885CA2 4603/4885 |
| US-10906932-B2 | Cyclising peptides | VIP, NGLY1, NPPA | CA12 692/4885CA1 654/4885CA2 3784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.